Fertility After Transvaginal Surgery or Uterine Artery Embolization Combined With Uterine Curettage in Patients With Cesarean Scar Pregnancy
1 other identifier
interventional
50
1 country
1
Brief Summary
To investigate the fertility in patients after treatment by transvaginal surgery or uterine artery embolization combined with uterine curettage
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2016
CompletedFirst Posted
Study publicly available on registry
October 14, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedOctober 14, 2016
August 1, 2016
1.7 years
August 9, 2016
October 12, 2016
Conditions
Outcome Measures
Primary Outcomes (3)
Duration of menstruation by questionnaire (days)
six months after treatment
Endocrine level by blood examination (FSH in IU/L)
six months after treatment
Volume of menstruation by questionnaire (in pictorial blood loss score)
six months after treatment
Secondary Outcomes (3)
The length of the CSD by MRI (millimeter)
six months after treatment
The width of the CSD by MRI (millimeter)
six months after treatment
The depth of the CSD by MRI (millimeter)
six months after treatment
Study Arms (1)
CSP;transvaginal surgery;UAE and D&C
OTHERCesarean scar pregnancy (CSP) refers to the implantation of a gestational sac with the myometrium at the site of a previous cesarean scar
Interventions
For cesarean scar pregnancy treatment
Eligibility Criteria
You may qualify if:
- increased levels of serum β-hCG and ultrasonography findings. The criteria for diagnosis by ultrasonography was the presence of the following: (1) an empty uterine cavity and endocervical canal; (2) detection of the placenta and/or a gestational sac embedded in the hysterectomy scar; (3) the presence of the gestation sac with or without a fetal pole and with or without fetal cardiac activity (depending on the gestational age) in the anterior part of the uterine isthmus; and (4) a thin (1-3 mm) or absent myometrial layer between the gestational sac and the bladder(24). All patients had taken Magnetic Resonance Imaging (MRI) to clarify the diagnosis . Pregnancy tissues were identified by histopathology examinations of the surgical tissues.
You may not qualify if:
- All enrolled patients had no contraindications for transvaginal surgery or UAE, including renal failure, active pelvic infection, clotting disorders, or known allergy to the contrast material.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gynecology, Shanghai First Maternity and Infant Hospital, affiliated to Tongji University
Shanghai, Shanghai Municipality, 201204, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xipeng Wang
Department of Gynecology, Shanghai First Maternity and Infant Hospital, affiliated to Tongji University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2016
First Posted
October 14, 2016
Study Start
November 1, 2016
Primary Completion
August 1, 2018
Study Completion
December 1, 2019
Last Updated
October 14, 2016
Record last verified: 2016-08